#vaccinessavelives

RSS feed

Laurent DECORY

Curevac partners with Bayer Pharma to boost mRNA Covid vaccine

After BioNTech SE and Pfizer, Moderna and NIH, 3rd mRNA Covid vaccine player CureVac now partners with fellow German company Bayer...

Laurent DECORY

Oxford/AstraZeneca Covid-19 vaccine: a vital opportunity for emerging markets

Oxford University/AstraZeneca Covid-19 vaccine, based on viral vector technology and now approved by UK authorities, will be vital for...

Laurent DECORY

mRNA-based vaccines: a story of immigration, science and resilience

Behind the success of BioNTech Pfizer and Moderna mRNA-based Covid vaccines, lays the story of 4 immigrants, Katalin Kariko, Ugur Sahin,...

Laurent DECORY

Moderna Covid-19 vaccine: 94% efficacy with easier storage

Following Pfizer-BioNTech 90% efficacy announcement, Moderna data show 94% efficacy against Covid-19, while allowing easier storage: long...

Laurent DECORY

mRNA-based treatments turn body cells into drug factories

mRNA treatments are about to revolutionize treatments of infectious and cancer diseases. After Covid-19 vaccines, next step will be...

Laurent DECORY

Taking necessary time to approve Covid19 vaccines

With growing anti-vax sentiment, and regardless of the political agenda, it is critical that the industry and regulatory authorities take...